Literature DB >> 32152718

Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice.

Serra Arf1, Isil Sayman Muslubas1, Mumin Hocaoglu1, Mehmet Giray Ersoz1, Hakan Ozdemir2, Murat Karacorlu3.   

Abstract

PURPOSE: To classify the types of diabetic macular edema (DME) and evaluate its morphological features on spectral domain optical coherence tomography (SD-OCT) and determine correlations between visual acuity and OCT findings.
METHODS: We assessed 406 eyes of 309 patients with a diagnosis of DME retrospectively. Three types based on SD-OCT were identified: diffuse macular edema, cystoid macular edema, and cystoid degeneration. Morphological features such as serous macular detachment (SMD), vitreomacular interface abnormalities (VMAI), hard exudates, photoreceptor status, and correlations between visual acuity and those morphological features were also evaluated by SD-OCT.
RESULTS: The most common type of DME was cystoid edema (68.5%). No statistically significant difference was found between groups in sex (P = 0.40), type of diabetes (P = 0.50), or diabetic retinopathy (P = 0.78). However, the duration of symptoms and BCVA was significantly lower in the group with cystoid degeneration compared with the group with cystoid edema (P < 0.001) and the group with diffuse macular edema (P < 0.001). In the group with cystoid degeneration compared with the groups with cystoid and diffuse edema, the central fovea and central subfield were significantly thicker (both (P < 0.001), the subfoveal choroid was significantly thinner (P = 0.049), rate of serous macular detachment was significantly lower (P < 0.001), and the rate of outer retinal damage was significantly higher (P < 0.001).
CONCLUSIONS: Cystoid macular degeneration, which is consistent with poor functional and morphological outcomes, should be differentiated from cystoid macular edema. Serous macular detachment, which is mostly seen in eyes with early stages of DME, should be evaluated as an accompanying morphological finding rather than a type of DME.

Entities:  

Keywords:  Cystoid macular degeneration; Cystoid macular edema; Diabetic macular edema; Diffuse macular edema; SD-OCT; Serous macular detachment

Mesh:

Year:  2020        PMID: 32152718     DOI: 10.1007/s00417-020-04640-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  3 in total

1.  Factors associated with 1-year visual response following intravitreal bevacizumab treatment for diabetic macular edema: a retrospective single center study.

Authors:  Janejit Choovuthayakorn; Apichat Tantraworasin; Phichayut Phinyo; Jayanton Patumanond; Paradee Kunavisarut; Titipol Srisomboon; Pawara Winaikosol; Direk Patikulsila; Voraporn Chaikitmongkol; Nawat Watanachai; Kessara Pathanapitoon
Journal:  Int J Retina Vitreous       Date:  2021-03-04

2.  En face image-based classification of diabetic macular edema using swept source optical coherence tomography.

Authors:  Atsushi Fujiwara; Yuki Kanzaki; Shuhei Kimura; Mio Hosokawa; Yusuke Shiode; Shinichiro Doi; Kosuke Takahashi; Ryo Matoba; Yuki Morizane
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

3.  Optical Coherence Tomography Combined with Fluorescein Fundus Angiography under Intelligent Algorithm to Evaluate the Clinical Efficacy of Ranibizumab Combined with Panretinal Photocoagulation in the Treatment of Macular Edema of Diabetic Retinopathy Patients.

Authors:  Ling Li; Qing Zhou; Jing Huang
Journal:  Comput Math Methods Med       Date:  2022-05-02       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.